Cyclooxygenase Inhibitors

All categories
DBCAT003910Therapeutic category

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. A DrugBank category of 52 drugs. 35 of them are approved.

Also known as
Antagonists, Prostaglandin Synthesis · COX Inhibitors · Cyclo Oxygenase Inhibitors · Cyclo-Oxygenase Inhibitors · Inhibitors, Cyclo Oxygenase
Drugs

and 27 more with a free account

What you can answer from here — as of July 05, 2019

52DrugsEach linked to its full drug card
Sign in
96Drug targetsEvery drug–target pair in the class, with bond type
Sign in
27,728Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
30Routes of administrationHow the drugs in this class are given
Sign in
2SubcategoriesNarrower classes within this one
Sign in

Which targets do Cyclooxygenase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In